• Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardio...

• Patoulias Dimitrios

• Imprialos Konstantinos, Stavropoulos Konstantinos, Doumas Michael

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 331 ~ 332

• Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and s...

• Kumar Rahul

• Hsiang John Chen, Tan Jessica, Thurairajah Prem Harichander

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 326 ~ 330

• Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compen...

• Hassan Elham Ahmed

• El-Din Abdel Rehim Abeer Sharaf, Abdel-Malek Mohamed Omar, Ahmed Asmaa Omar, Abbas Nourhan Mahmoud

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 317 ~ 325

• Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lym...

• Wong Linda

• Bozhilov Kliment, Hernandez Brenda Y., Kwee Sandi, Chan Owen, Ellis Luke, Le Marchand Loic

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 305 ~ 316

• Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with...

• Banitalebi Ebrahim

• Faramarzi Mohammad, Nasiri Samira, Mardaniyan Majid, Rabiee Vahid

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 294 ~ 304

• Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with ent...

• Kim David Soo-Ik

• Jeon Mi-Young, Lee Hye-Won, Kim Beom-Kyung, Park Jun-Yong, Kim Do-Young, Ahn Sang-Hoon, Ha...

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 283 ~ 293

• How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

• Yu Jung-Hwan

• Lee Jin-Woo

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 280 ~ 282

• Sarcopenia: Ammonia metabolism and hepatic encephalopathy

• Jindal Ankur

• Jagdish Rakesh Kumar

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 270 ~ 279

• Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

• Hanouneh Ibrahim A.

• Alkhouri Naim, Singal Amit G.

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 264 ~ 269

• Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 u...

• Kim Tae-Hyung

• Kim So-Yeon, Tang An, Lee Jeong-Min

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 245 ~ 263

• Development and surveillance of hepatocellular carcinoma in patients with sustained virologic respon...

• Na Seong-Kyun

• Song Byung-Cheol

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 234 ~ 244

• Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers

• Kim Yeun-Yoon

• Park Mi-Suk, Aljoqiman Khalid Suliman, Choi Jin-Young, Kim Myeong-Jin

• Clinical and Molecular Hepatology   2019  Volume.25  No.3 223 ~ 233